Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Hypertension Reports
Published in: Current Hypertension Reports 1/2015

01-01-2015 | Pediatric Hypertension (B Falkner, Section Editor)

Cognitive Function in Hypertensive Children

Authors: Marc B. Lande, Juan C. Kupferman

Published in: Current Hypertension Reports | Issue 1/2015

Login to get access

Abstract

Young hypertensive adults demonstrate decreased performance on neurocognitive testing compared with that of normotensive controls. There is emerging, preliminary evidence that children with hypertension also manifest cognitive differences when compared to normotensive controls. These preliminary studies consist mostly of database and single-center studies that focus primarily on differences in neurocognitive test performance and differences in cerebrovascular reactivity between hypertensive and normotensive subjects. Lessons from the literature on cognition in adult hypertensives and experience from the preliminary studies in children informed the design of a current, multicenter, ongoing study of cognition in children with primary hypertension.
Literature
1.
McNiece KL, Poffenbarger TS, Turner JL, Franco KD, Sorof JM, Portman RJ. Prevalence of hypertension and pre-hypertension among adolescents. J Pediatr. 2007;150(6):640,4, 644.e1.
2.
McNiece KL, Gupta-Malhotra M, Samuels J, Bell C, Garcia K, Poffenbarger T, et al. Left ventricular hypertrophy in hypertensive adolescents: analysis of risk by 2004 national high blood pressure education program working group staging criteria. Hypertension. 2007;50(2):392–5.CrossRefPubMedCentralPubMed
3.
Lande MB, Carson NL, Roy J, Meagher CC. Effects of childhood primary hypertension on carotid intima media thickness: a matched controlled study. Hypertension. 2006;48(1):40–4.CrossRefPubMed
4.
National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114(2 Suppl 4th Report):555–76.
5.
Lande MB, Kupferman JC, Adams HR. Neurocognitive alterations in hypertensive children and adolescents. J Clin Hypertens (Greenwich). 2012;14(6):353–9.CrossRef
6.
Launer LJ, Ross GW, Petrovitch H, Masaki K, Foley D, White LR, et al. Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging. 2000;21(1):49–55.CrossRefPubMed
7.
Waldstein SR, Snow J, Muldoon MF, Katzel LI. Neuropsychological consequences of cardiovascular disease. In: Tarter RE, Butters M, Beers SR, editors. Medical neuropsychology. 2nd ed. New York: Kluwer Academic/Plenum; 2001. p. 51,51-83.
8.
Waldstein SR. Hypertension and neuropsychological function: a lifespan perspective. Exp Aging Res. 1995;21(4):321–52.CrossRefPubMed
9.
Suhr JA, Stewart JC, France CR. The relationship between blood pressure and cognitive performance in the Third National Health and Nutrition Examination Survey (NHANES III). Psychosom Med. 2004;66(3):291–7.PubMed
10.
Waldstein SR, Jennings JR, Ryan CM, Muldoon MF, Shapiro AP, Polefrone JM, et al. Hypertension and neuropsychological performance in men: interactive effects of age. Health Psychol. 1996;15(2):102–9.CrossRefPubMed
11.
Waldstein SR, Manuck SB, Ryan CM, Muldoon MF. Neuropsychological correlates of hypertension: review and methodologic considerations. Psychol Bull. 1991;110(3):451–68.CrossRefPubMed
12.
A compendium of neuropsychological tests: administration, norms, and commentary. Straus, E.; Sherman, E.M.S.; Spreen, O. 3rd ed. New York: Oxford University Press; 2006.
13.
Pennington BF, Ozonoff S. Executive functions and developmental psychopathology. J Child Psychol Psychiatry. 1996;37(1):51–87.CrossRefPubMed
14.
Anderson VA, Anderson P, Northam E, Jacobs R, Catroppa C. Development of executive functions through late childhood and adolescence in an Australian sample. Dev Neuropsychol. 2001;20(1):385–406.CrossRefPubMed
15.
Hsu NS, Novick JM, Jaeggi SM. The development and malleability of executive control abilities. Front Behav Neurosci. 2014;8:221.PubMedCentralPubMed
16.
17.
Lande MB, Kaczorowski JM, Auinger P, Schwartz GJ, Weitzman M. Elevated blood pressure and decreased cognitive function among school-age children and adolescents in the United States. J Pediatr. 2003;143(6):720–4.CrossRefPubMed
18.
Lande MB, Adams H, Falkner B, Waldstein SR, Schwartz GJ, Szilagyi PG, et al. Parental assessments of internalizing and externalizing behavior and executive function in children with primary hypertension. J Pediatr. 2009;154(2):207–12.CrossRefPubMedCentralPubMed
19.
Gioia GA, Isquith PK, Guy SC, Kenworthy L. Behavior rating inventory of executive function. Lutz: Pyschological Assessments Resources; 2000.
20.
Lande MB, Adams H, Falkner B, Waldstein SR, Schwartz GJ, Szilagyi PG, et al. Parental assessment of executive function and internalizing and externalizing behavior in primary hypertension after anti-hypertensive therapy. J Pediatr. 2010;157(1):114–9.CrossRefPubMedCentralPubMed
21.
Ditto B, Seguin JR, Tremblay RE. Neuropsychological characteristics of adolescent boys differing in risk for high blood pressure. Ann Behav Med. 2006;31(3):231,232-237.
22.
Adams HR, Szilagyi PG, Gebhardt L, Lande MB. Learning and attention problems among children with pediatric primary hypertension. Pediatrics. 2010;126(6):e1425–9.CrossRefPubMed
23.
Flynn JT, Mitsnefes M, Pierce C, Cole SR, Parekh RS, Furth SL, et al. Blood pressure in children with chronic kidney disease: a report from the chronic kidney disease in children study. Hypertension. 2008;52(4):631–7.CrossRefPubMedCentralPubMed
24.
Lande MB, Gerson AC, Hooper SR, Cox C, Matheson M, Mendley SR, et al. Casual blood pressure and neurocognitive function in children with chronic kidney disease: a report of the children with chronic kidney disease cohort study. Clin J Am Soc Nephrol: CJASN. 2011;6(8):1831–7.CrossRefPubMedCentralPubMed
25.
Settakis G, Pall D, Molnar C, Bereczki D, Csiba L, Fulesdi B. Cerebrovascular reactivity in hypertensive and healthy adolescents: TCD with vasodilatory challenge. J Neuroimaging. 2003;13(2):106–12.CrossRefPubMed
26.
Settakis G, Pall D, Molnar C, Katona E, Bereczki D, Fulesdi B. Hyperventilation-induced cerebrovascular reactivity among hypertensive and healthy adolescents. Kidney Blood Press Res. 2006;29(5):306–11.CrossRefPubMed
27.
Pall D, Lengyel S, Komonyi E, Molnar C, Paragh G, Fulesdi B, et al. Impaired cerebral vasoreactivity in white coat hypertensive adolescents. Eur J Neurol. 2011;18(4):584–9.CrossRefPubMed
28.••
Wong LJ, Kupferman JC, Prohovnik I, Kirkham FJ, Goodman S, Paterno K, et al. Hypertension impairs vascular reactivity in the pediatric brain. Stroke. 2011;42(7):1834–8. This report establishes that children with elevated blood pressure confirmed by ambulatory blood pressure monitoring have blunted cerebrovascular reactivity compared with normotensive control subjects.CrossRefPubMed
29.•
Ostrovskaya MA, Rojas M, Kupferman JC, Lande MB, Paterno KJ, Brosgol Y, et al. Pediatric primary hypertension: measures of executive function correlate to abnormal cerebral blood velocity response to hypercapnia. J Pediatr Neurol. 2013. doi:10.​1177/​0883073813494264​. While the sample size is small, this is the first report to associated blunted cerebrovascular reactivity to decreased executive function in children with hypertension.
30.•
Lande MB, Adams HR, Kupferman JC, Hooper SR, Szilagyi PG, Batisky DL. A multicenter study of neurocognition in children with hypertension: methods, challenges, and solutions. J Am Soc Hypertens. 2013;7(5):353–62. This report details the methods of an ongoing, multicenter study to determine the effects of hypertension on cognition in children. The report outlines challenges that are particularly relevant to the study of cognition in this population.CrossRefPubMedCentralPubMed
31.
Urbina E, Alpert B, Flynn J, Hayman L, Harshfield GA, Jacobson M, et al. Ambulatory blood pressure monitoring in children and adolescents: recommendations for standard assessment: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the Council on Cardiovascular Disease in the Young and the Council for High Blood Pressure Research. Hypertension. 2008;52(3):433–51.CrossRefPubMed
32.
Owens JA. Neurocognitive and behavioral impact of sleep disordered breathing in children. Pediatr Pulmonol. 2009;44(5):417–22.CrossRefPubMed
33.
Chervin RD, Weatherly RA, Garetz SL, Ruzicka DL, Giordani BJ, Hodges EK, et al. Pediatric sleep questionnaire: prediction of sleep apnea and outcomes. Arch Otolaryngol Head Neck Surg. 2007;133(3):216–22.CrossRefPubMed
34.
Yau PL, Castro MG, Tagani A, Tsui WH, Convit A. Obesity and metabolic syndrome and functional and structural brain impairments in adolescence. Pediatrics. 2012;130(4):e856–64.CrossRefPubMedCentralPubMed
35.
Falleti MG, Maruff P, Collie A, Darby DG. Practice effects associated with the repeated assessment of cognitive function using the CogState battery at 10-minute, one week and one month test-retest intervals. J Clin Exp Neuropsychol. 2006;28(7):1095–112.CrossRefPubMed
36.
Conners CK, Staff MHS. Conners’ continuous performance test II. Computer program for windows technical guide and software manual. North Tonawanda: Multi-Health Systems, Inc.; 2001.
37.
Lande MB, Hooper SR, Batisky DL, Kupferman JC, Szilagyi PG, Samuels JA, et al. Sleep disordered breathing as measured by SRBD-PSQ and neurocognition in children with hypertension. Am J Hyperten; 2014, in press.
38.
Acosta AA. Obstructive sleep apnea and hypertension. In: Flynn JT, Ingelfinger JR, Portman RJ, editors. Pediatric hypertension. 3rd ed. New York: Humana; 2013.
39.
Beebe DW, Ris MD, Kramer ME, Long E, Amin R. The association between sleep disordered breathing, academic grades, and cognitive and behavioral functioning among overweight subjects during middle to late childhood. Sleep. 2010;33(11):1447–56.PubMedCentralPubMed
Metadata
Title
Cognitive Function in Hypertensive Children
Authors
Marc B. Lande
Juan C. Kupferman
Publication date
01-01-2015
Publisher
Springer US
Published in
Current Hypertension Reports / Issue 1/2015
Print ISSN: 1522-6417
Electronic ISSN: 1534-3111
DOI
https://doi.org/10.1007/s11906-014-0508-y

Other articles of this Issue 1/2015

Current Hypertension Reports 1/2015 Go to the issue

Antihypertensive Agents: Mechanisms of Drug Action (M Ernst, Section Editor)

Plasma Renin Testing to Guide Antihypertensive Therapy

Antihypertensive Agents: Mechanisms of Drug Action (M Ernst, Section Editor)

Inflammation and Hypertension: New Understandings and Potential Therapeutic Targets

Hypertension and Obesity (E Reisin, Section Editor)

Hypertension and Insulin Resistance: Implications of Mitochondrial Dysfunction

Antihypertensive Agents: Mechanisms of Drug Action (M Ernst, Section Editor)

Vasopressin Receptor Antagonists

Pediatric Hypertension (B Falkner, Section Editor)

Treatment of Hypertension in Children with Chronic Kidney Disease

Antihypertensive Agents: Mechanisms of Drug Action (M Ernst, Section Editor)

Dual Renin-Angiotensin-Aldosterone Blockade: Promises and Pitfalls
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits